000 01472 a2200409 4500
005 20250513203918.0
264 0 _c20000424
008 200004s 0 0 eng d
022 _a0006-8993
024 7 _a10.1016/s0006-8993(99)02392-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerguson, S A
245 0 0 _aPrenatal exposure to the dopamine agonist SKF-38393 disrupts the timing of the initial response of the suprachiasmatic nucleus to light.
_h[electronic resource]
260 _bBrain research
_cMar 2000
300 _a284-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntibodies
650 0 4 _aCircadian Rhythm
_xphysiology
650 0 4 _aDopamine
_xphysiology
650 0 4 _aDopamine Agonists
_xpharmacology
650 0 4 _aFemale
650 0 4 _aNeurons
_xchemistry
650 0 4 _aPhotic Stimulation
650 0 4 _aPregnancy
650 0 4 _aPrenatal Exposure Delayed Effects
650 0 4 _aProto-Oncogene Proteins c-fos
_xanalysis
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSuprachiasmatic Nucleus
_xcytology
700 1 _aRowe, S A
700 1 _aKrupa, M
700 1 _aKennaway, D J
773 0 _tBrain research
_gvol. 858
_gno. 2
_gp. 284-9
856 4 0 _uhttps://doi.org/10.1016/s0006-8993(99)02392-6
_zAvailable from publisher's website
999 _c10662704
_d10662704